In the present model, we further expand the mechanisms of MDSCs to include both the secretion of Arg-I and NO by MDSCs, which inhibit Teff cytotoxicity and induce Treg expansion, and CCL2 secretion by breast cancer cells, which facilitates MDSC recruitment into the tumor. Here, LNCARGI is linked to neoplasm.